Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | -0.83% | 191.56 | 1.2% | $567.63m | |
| GILD | Gilead Sciences, Inc. | -0.97% | 70.49 | 0.9% | $501.34m | |
| BIIB | Biogen Inc. | -1.94% | 318.90 | 1.3% | $457.42m | |
| CELG | Celgene Corporation | -4.05% | 71.02 | 1.2% | $422.10m | |
| ILMN | Illumina, Inc. | -5.73% | 310.39 | 3.5% | $402.00m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -2.83% | 346.56 | 2.6% | $291.08m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -4.27% | 172.85 | 1.9% | $281.35m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -3.92% | 118.60 | 2.0% | $203.65m | |
| A | Agilent Technologies, Inc. | -4.12% | 64.50 | 1.5% | $169.81m | |
| LGND | Ligand Pharmaceuticals Incorporated | -1.97% | 155.47 | 23.3% | $152.44m | |
| EXAS | Exact Sciences Corporation | -8.54% | 68.25 | 25.3% | $149.11m | |
| SRPT | Sarepta Therapeutics, Inc. | -3.70% | 120.82 | 16.4% | $136.29m | |
| ECYT | Endocyte, Inc. | -0.04% | 23.55 | 2.0% | $123.58m | |
| INCY | Incyte Corporation | -4.80% | 62.86 | 2.5% | $111.57m | |
| BMRN | BioMarin Pharmaceutical Inc. | -2.72% | 93.07 | 4.3% | $110.69m |
Company Profile
Solid Biosciences, Inc. engages in the development of treatments for patients with Duchenne muscular dystrophy. It develops gene therapies, disease modifying therapies, and assistive devices for the cure of DMD. The company was founded by Ilan Ganot, Andrey Zarur, and Gilad Hayeem in March 2013 and is headquartered in Cambridge, MA.